Multipharma Continues to Grow, but Investments Melt Away Profits - RetailDetail EU
2 Articles
2 Articles
Multipharma continues to grow, but investments melt away profits - RetailDetail EU
The Belgian pharmacy group Multipharma achieved impressive growth in 2024, even without the acquisition of the Goed pharmacies. However, net profits halved due to significant investments, including in IT and supply chain. Pre-acquisition costs Multipharma once again achieved a turnover of more than half a billion euros last year. With an increase of 6.3% to 549.7 million euros in turnover, the group accounted for 5% of the market share. However,…
09:16 Multipharma saw its turnover increase in 2024, but the country's largest pharmacy group failed to increase its profits.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium